STAA vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

STAA

48.1
AI Score
VS
XRAY Wins

XRAY

50.2
AI Score

Investment Advisor Scores

STAA

48score
Recommendation
HOLD

XRAY

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric STAA XRAY Winner
Forward P/E 62.5 6.3291 XRAY
PEG Ratio 0.7622 0.633 XRAY
Revenue Growth 111.0% -4.1% STAA
Earnings Growth -10.5% 15.2% XRAY
Tradestie Score 48.1/100 50.2/100 XRAY
Profit Margin 1.1% -15.0% STAA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

STAA 1M: +13.6% · 3M: -3.8% XRAY 1M: -2.9% · 3M: -26.5%

Current Technical Phase

STAA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.6 · Price: $22.49

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.1 · Price: $9.50

Fundamentals Snapshot

Metric STAA XRAY
Market Cap — —
Forward P/E 20.2 6.4
Trailing P/E 270.1 —
Revenue (TTM) — —
Revenue Growth 1.1% 0.0%
Gross Margin 0.8% 0.5%
Operating Margin 0.1% 0.1%
EPS 0.08 -2.73
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.